分组1 - Gevo, Inc. reported a quarterly loss of $0.09 per share, which was better than the Zacks Consensus Estimate of a loss of $0.10, and compared to a loss of $0.08 per share a year ago, indicating an earnings surprise of 10% [1] - The company posted revenues of $29.11 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 10.47%, and showing significant growth from year-ago revenues of $3.99 million [2] - Gevo has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] 分组2 - The stock has underperformed the market, losing about 43.1% since the beginning of the year, while the S&P 500 has only declined by 0.6% [3] - The current consensus EPS estimate for the coming quarter is -$0.05 on revenues of $45.19 million, and -$0.23 on revenues of $166.86 million for the current fiscal year [7] - The Zacks Industry Rank for Alternative Energy - Other is currently in the bottom 45% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8]

Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -22.22%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.02, delivering no surprise.Over the last four quarters, the company has s ...

MacroGenics (MGNX) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.56%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%.Over the last four quarters, the compan ...

Seer, Inc. (SEER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.11%. A quarter ago, it was expected that this company would post a loss of $0.40 per share when it actually produced a loss of $0.34, delivering a surprise of 15%.Over the last four quarters, the company has surpassed consens ...

Hyliion Holdings Corp. (HYLN) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25%. A quarter ago, it was expected that this company would post a loss of $0.07 per share when it actually produced a loss of $0.08, delivering a surprise of -14.29%.Over the last four quarters, the company has su ...

Exelixis (EXEL) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 47.62%. A quarter ago, it was expected that this drug developer would post earnings of $0.51 per share when it actually produced earnings of $0.55, delivering a surprise of 7.84%.Over the last four quarters, the company h ...

Zevra Therapeutics (ZVRA) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 71.43%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.39 per share when it actually produced a loss of $0.67, delivering a surprise of -71.79%.Over the last four quart ...

Webtoon Entertainment (WBTN) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $1.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this online storytelling platform for comics and cartoons would post a loss of $0.08 per share when it actually produced a loss of $0.03, delivering a surprise of 62.5 ...

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.07 per share when it actually produced a loss of $0.06, delivering a surprise of 14.29%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Biodesix, which belongs to the Zacks Medi ...

Editor's note: Seeking Alpha is proud to welcome Jaime Perez as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.With over two decades of experience, Jaime is a former sell-side and buy-side equity research analyst with deep and extensive knowledge of the energy and clean technology sector. He is a long-only fundamental analyst focusing on small to mid-ca ...